Erythropoietin and a hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHDi) lowers FGF23 in a model of chronic kidney disease (CKD).
Physiol Rep. 2020 Jun;8(11):e14434. doi: 10.14814/phy2.14434.
Physiol Rep. 2020.
PMID: 32476270
Free PMC article.